AstraZeneca

AstraZeneca wins FDA Approval for Prostate Cancer and Reduces IBD Pipeline

AstraZeneca wins FDA Approval for Prostate Cancer and Reduces IBD PipelineAstraZeneca wins FDA Approval for Prostate Cancer and Reduces IBD Pipeline

Thursday, the FDA supported AstraZeneca and Merck's Lynparza (olaparib) for the therapy of grown-ups with metastatic emasculation safe prostate malignant…

FDA approves AstraZeneca’s Covid antibody treatment for immunocompromised

FDA approves AstraZeneca’s Covid antibody treatment for immunocompromisedFDA approves AstraZeneca’s Covid antibody treatment for immunocompromised

Before being exposed to the coronavirus, the Food and Drug Administration approved the first injectable monoclonal antibody cocktail for long-term…